CoreCap Advisors’s Zymeworks ZYME Stock Holding History

CoreCap Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18	Closed	-$451	–	3294
2026 Q1	$451	Hold	18	–	–	﹤0.01%	2668
2025 Q4	$474	Hold	18	–	–	﹤0.01%	2711
2025 Q3	$307	Hold	18	–	–	﹤0.01%	2625
2025 Q2	$226	Hold	18	–	–	﹤0.01%	2610
2025 Q1	$214	Hold	18	–	–	﹤0.01%	2950
2024 Q4	$264	Hold	18	–	–	﹤0.01%	2668
2024 Q3	$226	Hold	18	–	–	﹤0.01%	2492
2024 Q2	$153	Hold	18	–	–	﹤0.01%	1518
2024 Q1	$189	Buy	+18	New	+$200	﹤0.01%	2413
2022 Q4	$141	Buy	+18	New	+$126	﹤0.01%	2293
2022 Q3	–	Sell	-18	Closed	–	–	2162
2022 Q2	$0	Buy	+18	New	+$109	﹤0.01%	2298
2022 Q1	–	Sell	-18	Closed	-$1K	–	2160
2021 Q4	$1K	Buy	+18	New	+$375	﹤0.01%	2295

Other funds holding ZYME

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors's ZYME Position: Q2 2026 in Review

CoreCap Advisors sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 18 shares — an estimated $451 sold.

CoreCap Advisors first reported a position in ZYME in Q4 2021 and held it in 12 quarters. The position peaked at $1K in Q4 2021. 8 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

CoreCap Advisors reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
CoreCap Advisors sold 18 Zymeworks shares in Q2 2026, an estimated $451.
CoreCap Advisors first reported a position in Zymeworks in Q4 2021 and held it in 12 quarters.
CoreCap Advisors's Zymeworks position peaked at $1K in Q4 2021.
8 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.